Dr. Michael Anderson on effectiveness of monoclonal antibodies | COVID-19 Update for June 24, 2021
Jun 24, 2021

American Medical Association (AMA)
16.2K subscribers

A discussion with with Dr. Michael Anderson, senior advisor at the HHS Office of the Assistant Secretary for Preparedness and Response in Washington, D.C., about what physicians need to know about monoclonal antibody treatments and their incredible effectiveness in helping certain patients avoid hospitalization for COVID-19. For more information and to find infusion sites in your area, visit: 0:00 AMA COVID-19 Update for June 24, 2021

0:21 Explain the science behind monoclonal antibody treatments 1:45
When is the use of this treatment most effective and what type of patients benefit most?
3:08 Have we been able to move past challenges we faced early in the pandemic?
5:07 Discuss standout key benefits with monoclonal antibody treatments thus far
6:32 Are we still seeing these benefits against new variants?
8:15 What do you see as physicians’ primary role in increasing access and use of these treatments?
10: 08 How can physicians find out where to access this treatment locally? 11:41 What’s your message to those experiencing hesitancy in actively referring patients because of its EUA status?
13:26 Any side effects or guidance on vaccination after receiving monoclonal antibody treatment that physicians need to know?
15:05 Discuss the 90-day window between monoclonal antibody treatment and vaccination
15:50 Do you think there will be a need for monoclonal antibody treatments in the future? Stay up to date on the latest information about the pandemic: Visit the COVID-19 Daily Video Updates page for more videos in this series: